From: Synthesis, biological evaluation and molecular docking analysis of vaniline–benzylidenehydrazine hybrids as potent tyrosinase inhibitors
Compounds
R
IC50 (µM)a
IC50 (µM) a
4a
37.09 ± 1.02
4g
4.58 ± 1.23
4b
15.21 ± 1.34
4h
10.00 ± 1.6
4c
35.63 ± 2.8
4i
1.58 ± 2.76
4d
20.95 ± 2.09
4j
17.01 ± 2.03
4e
1.95 ± 2.34
4k
5.84 ± 1.9
4f
29.06 ± 0.89
Kojic acidb
9.3 ± 1.27